3 Medical Routines That Older People May Not Need

Why It Matters

Eliminating low‑value procedures and drugs improves patient safety, cuts costs, and aligns care with realistic life‑expectancy goals for the aging population.

Key Takeaways

• Colonoscopies after 75 show minimal mortality benefit
• Actinic keratoses often benign; removal may be unnecessary
• Low-dose thyroid hormone can be stopped safely in many seniors
• Over‑screening raises complication risk and healthcare costs

Pulse Analysis

Recent studies are reshaping how clinicians approach cancer screening in the oldest patients. Data from large cohort analyses indicate that colonoscopies performed after age 75 yield only a marginal reduction in colorectal‑cancer mortality, while the procedure carries measurable risks such as bleeding, perforation, and the need to pause anticoagulants. As a result, major societies now recommend individualized decision‑making rather than routine repeat exams for seniors in good health. This shift reflects a broader move toward value‑based care that balances life expectancy with procedural harm.

Actinic keratoses, the rough, red patches that accumulate from decades of sun exposure, have long been treated aggressively because of their potential to evolve into squamous‑cell carcinoma. However, recent dermatologic trials show that the majority of these lesions remain indolent, and immediate excision or cryotherapy offers little advantage over watchful waiting in patients over 80. By sparing seniors unnecessary procedures, physicians reduce wound‑healing complications, avoid cosmetic concerns, and lower outpatient costs. The emerging consensus encourages clinicians to assess lesion number, size, and patient preference before recommending removal.

Thyroid hormone replacement is one of the most prescribed chronic therapies, yet evidence now suggests many older adults can taper or discontinue low‑dose levothyroxine without adverse outcomes. Studies tracking cardiovascular events and bone density found no increase in risk when doses were reduced in patients with borderline thyroid‑stimulating hormone levels. Deprescribing these medications helps combat polypharmacy, diminishes drug‑interaction hazards, and can improve patients’ sense of autonomy. As health systems prioritize medication safety, clinicians are urged to review thyroid regimens annually and consider dose reduction as part of comprehensive geriatric care.